Known targets — ChEMBL curated mechanism
rplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of Stearic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GPR84 | Q9NQS5 | 7/20 | 0.59 |
| ▸ | PPARG | P37231 | 7/20 | 0.59 |
| ▸ | PPARD | Q03181 | 7/20 | 0.59 |
| ▸ | PPARA | Q07869 | 7/20 | 0.59 |
| ▸ | HDAC11 | Q96DB2 | 5/20 | 0.59 |
| ▸ | TSHR | P16473 | 4/20 | 0.59 |
| ▸ | PTPN1 | P18031 | 3/20 | 0.59 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.59 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.59 |
| ▸ | TLR2 | O60603 | 2/20 | 0.59 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.59 |
| ▸ | FABP4 | P15090 | 2/20 | 0.59 |
| ▸ | MEN1 | O00255 | 2/20 | 0.59 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.59 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.59 |
| ▸ | SLC22A8 | Q8TCC7 | 1/20 | 0.59 |
| ▸ | ESR1 | P03372 | 1/20 | 0.59 |
| ▸ | PDE4A | P27815 | 1/20 | 0.59 |
| ▸ | PDE3A | Q14432 | 1/20 | 0.59 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.59 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Decanoic Acid SCHEMBL29072348 | 0.98 | GPR84 (0.61) | GPR84PPARGPPARDPPARAHDAC11 | |
| Dodecanoate SCHEMBL4239059 | 0.98 | GPR84 (0.61) | GPR84PPARGPPARDPPARAHDAC11 | |
| Myristic Acid SCHEMBL4244025 | 0.98 | GPR84 (0.61) | GPR84PPARGPPARDPPARAHDAC11 | |
| Stearic Acid SCHEMBL689939 | 0.98 | GPR84 (0.61) | GPR84PPARGPPARDPPARAHDAC11 | |
| Palmitic Acid SCHEMBL2858784 | 0.98 | GPR84 (0.61) | GPR84PPARGPPARDPPARAHDAC11 | |
| Behenic Acid SCHEMBL2860357 | 0.98 | GPR84 (0.61) | GPR84PPARGPPARDPPARAHDAC11 | |
| Hexanoate SCHEMBL29072341 | 0.96 | AKR1B1 (0.59) | GPR84PPARGPPARDPPARAHDAC11 | |
| Adipic Acid SCHEMBL9065306 | 0.91 | BLM (0.64) | HDAC11TSHRALDH1A1KMT2AMEN1 | |
| Stearic Acid SCHEMBL28166526 | 0.90 | GPR84 (0.59) | GPR84PPARGPPARDPPARAHDAC11 | |
| Myristic Acid SCHEMBL2865131 | 0.89 | GPR84 (0.63) | GPR84PPARGPPARDPPARAHDAC11 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-102802601-B | Tyr-Arg dipeptides is preventing the cosmetic applications of skin sagging | 赛德玛公司 | 2016-08-17 | — | — | CN | disclosed |
| CN-101854907-B | Cosmetic composition comprising hydroxymethionine and 3-aminopropanesulfonic acid | SEDERMA SA | 2014-06-18 | — | — | CN | disclosed |
| CN-102802601-A | Cosmetic use of tyr-arg dipeptide to combat cutaneous sagging | SEDERMA SA | 2012-11-28 | — | — | CN | disclosed |
| CN-102245643-A | Cosmetic composition containing acetylated oligoglucuronans | SEDERMA SA | 2011-11-16 | — | — | CN | disclosed |
| CN-101854907-A | Cosmetic composition comprising hydroxymethionine and 3-aminopropanesulfonic acid | SEDERMA SA | 2010-10-06 | — | — | CN | disclosed |
| CN-101182299-A | Mydrial derivates,preparation method of mydrial derivates and cosmetics or skin medicinal composition | SEDERMA SA (FR) | 2008-05-21 | — | — | CN | disclosed |
| US-20010038829-A1 | Cosmetic | KAO CORPORATION (JP) | 2001-11-08 | — | — | US | disclosed |
| EP-1145708-A2 | Cosmetic and use thereof | KAO CORPORATION (JP) | 2001-10-17 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20010038829-A1 | Cosmetic | CUTA, H1-0, TYR | GPR84 3391/4885PPARG 395/4885PPARD 769/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.